FMS News and Press, Fresenius Medical Care AG From 03/05/21

The continued rise in yields has spooked investors, leading to a week of wild market swings. But David Cohne has the best way to play this volatility. Learn why he thinks investors should consider Johnson & Johnson (JNJ), Novartis (NVS), and Fresenius Medical Care (FMS). Hold onto yo...

Fresenius management is reviewing its group structure to make sure capital markets give it more appreciation. We remain skeptical given its opaque disclosure. The outlook for FY12/2021 is less than robust, as we estimate flat net income and falling free cash flow generation YoY. Accou...

Image source: The Motley Fool. Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) Q4 2020 Earnings Call Feb 23, 2021 , 9:30 a.m. ET Operator Continue reading For further details see: Fresenius Medical Care AG & Co. KGaA (FMS) Q4 202...

Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2020 Earnings Conference Call February 23, 2021 09:30 AM ET Company Participants Dominik Heger - Executive Vice President & Head, Investor Relations, Strategic Development & Communications Rice Powell - Chief Executive Officer & Ch...

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2020 Q4 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2020 Q4 - Results - Earnings Call Presentation

Biotech firm Humacyte Inc. agreed Wednesday to a merger with SPAC Alpha Healthcare Acquisition Corp. (AHAC) in a deal that values the target company at some $1.1B.AHAC, a special purpose acquisition company, popped as much as 17.9% intraday to a record $12.33 on the news. It was trading at $1...

Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $379, up 30% sequentiall...

Yesterday, Model N ([[MODN]] +4.3%) announced the financial results for the first quarter of fiscal 2021 where both revenue and EPS came ahead of expectation.Noting a 12% rise in Q1 FY21 Subscription revenue as a return to double-digit growth, BTIG upgrades the stock to buy from neu...

Fresenius Medical Care (FMS), down 12% premarket anticipates revenue growth of up to mid-single digits and assumes net income before restructuring to decline by up to 25% for 2021.The accelerating effects of excess mortality due to the COVID-19 are expected to have a significant adv...

Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven rebound in value stocks. My dividend income amounted to $3...